Clinical Trials Directory

Trials / Completed

CompletedNCT03195062

Fructose Extra-splanchnic Metabolism and Its Effects on Systemic Flux of Substrates (FruPP)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Lausanne · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In parallel to the dramatic rise in metabolic diseases and diabetes observed over the past fifty years, the generalization of added sugar in processed food led to a marked increase in fructose consumption in almost all countries, and epidemiological studies demonstrated that the consumption of sugar-sweetened beverage (containing at least 50% of fructose) is associated with the development of diabetes, hepatic steatosis, dyslipidemia and obesity. The objective of the study is to measure the amount of fructose that escape first-pass hepatic extraction after oral ingestion (fructose+glucose), and gain insights into its metabolic fates with the use of tracers.

Conditions

Interventions

TypeNameDescription
OTHERTest mealLiquid test meal (fructose+glucose)

Timeline

Start date
2017-03-23
Primary completion
2018-06-30
Completion
2018-08-31
First posted
2017-06-22
Last updated
2018-10-18

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03195062. Inclusion in this directory is not an endorsement.